We are building a Venture Capital firm focused on opportunistic investing in the psychedelics space. While many psychedelics are not currently legalized, our research and time within the industry has shown us that the likelihood of legalization over the next 2 years is extremely high. With multiple compounds already in phase III trials, and Ketamine recently released for sale as a nasal spray by Johnson and Johnson, we believe that psychedelics are the next frontier of both medical as well as recreationally available substances/pharmaceuticals.